These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35920665)

  • 1. Mutations in
    Poulton NC; Azadian ZA; DeJesus MA; Rock JM
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0090422. PubMed ID: 35920665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan.
    Saeed DK; Shakoor S; Razzak SA; Hasan Z; Sabzwari SF; Azizullah Z; Kanji A; Nasir A; Shafiq S; Ghanchi NK; Hasan R
    BMC Microbiol; 2022 Feb; 22(1):62. PubMed ID: 35209842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
    Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
    Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in
    Almeida DV; Converse PJ; Nuermberger EL
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0005223. PubMed ID: 36786606
    [No Abstract]   [Full Text] [Related]  

  • 5. Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis.
    Xu J; Li D; Shi J; Wang B; Ge F; Guo Z; Mu X; Nuermberger E; Lu Y
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0153222. PubMed ID: 37255473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline.
    Villellas C; Coeck N; Meehan CJ; Lounis N; de Jong B; Rigouts L; Andries K
    J Antimicrob Chemother; 2017 Mar; 72(3):684-690. PubMed ID: 28031270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a new combination therapy for tuberculosis with next generation benzothiazinones.
    Makarov V; Lechartier B; Zhang M; Neres J; van der Sar AM; Raadsen SA; Hartkoorn RC; Ryabova OB; Vocat A; Decosterd LA; Widmer N; Buclin T; Bitter W; Andries K; Pojer F; Dyson PJ; Cole ST
    EMBO Mol Med; 2014 Mar; 6(3):372-83. PubMed ID: 24500695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis.
    Almeida D; Ioerger T; Tyagi S; Li SY; Mdluli K; Andries K; Grosset J; Sacchettini J; Nuermberger E
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4590-9. PubMed ID: 27185800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in
    Guo Q; Bi J; Lin Q; Ye T; Wang Z; Wang Z; Liu L; Zhang G
    Front Cell Infect Microbiol; 2022; 12():807095. PubMed ID: 35694543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in
    Singh BK; Soneja M; Sharma R; Chaubey J; Kodan P; Jorwal P; Nischal N; Chandra S; Ramachandran R; Wig N
    Int J Mycobacteriol; 2020; 9(2):212-215. PubMed ID: 32474547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).
    Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.
    Nimmo C; Millard J; van Dorp L; Brien K; Moodley S; Wolf A; Grant AD; Padayatchi N; Pym AS; Balloux F; O'Donnell M
    Lancet Microbe; 2020 Aug; 1(4):e165-e174. PubMed ID: 32803174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones.
    Pasca MR; Degiacomi G; Ribeiro AL; Zara F; De Mori P; Heym B; Mirrione M; Brerra R; Pagani L; Pucillo L; Troupioti P; Makarov V; Cole ST; Riccardi G
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1616-8. PubMed ID: 20086151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.
    Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia.
    Martinez E; Hennessy D; Jelfs P; Crighton T; Chen SC; Sintchenko V
    Tuberculosis (Edinb); 2018 Jul; 111():31-34. PubMed ID: 30029911
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ismail N; Ismail NA; Omar SV; Peters RPH
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)].
    Mariandyshev AO; Khokhlov AL; Smerdin SV; Shcherbakova VS; Igumnova OV; Ozerova IV; Bolgarina AA; Nikitina NA
    Ter Arkh; 2020 Apr; 92(3):61-72. PubMed ID: 32598795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants and their association with phenotypic resistance to bedaquiline in
    Ismail N; Rivière E; Limberis J; Huo S; Metcalfe JZ; Warren RM; Van Rie A
    Lancet Microbe; 2021 Nov; 2(11):e604-e616. PubMed ID: 34796339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant
    Xu J; Converse PJ; Upton AM; Mdluli K; Fotouhi N; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
    Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.